China Biologic Products Holdings Inc (CBPO) stock is higher by 6.81% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives CBPO stock a score of 30 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 11. In addition to the average rating from Wall Street analysts, CBPO stock has a mean target price of 103. This means analysts expect the stock to lose 3.53% over the next 12 months. CBPO's rank also includes a long-term technical score of 20. The short-term technical score for CBPO is 58.
What's Happening with CBPO Stock Today
China Biologic Products Holdings Inc (CBPO) stock is lower by -0.21% while the S&P 500 is higher by 1.61% as of 1:35 PM on Monday, Sep 14. CBPO has fallen -$0.23 from the previous closing price of $107.00 on volume of 58,297 shares. Over the past year the S&P 500 is up 13.24% while CBPO is higher by 6.81%. CBPO earned $3.95 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 27.04.
Click Here to get the full Stock Score Report on China Biologic Products Holdings Inc (CBPO) Stock.